[
  {
    "ts": "2025-09-03T21:24:18+00:00",
    "headline": "Gilead starts building manufacturing hub under $32 billion planned US investments",
    "summary": "Major U.S. drugmakers such as Eli Lilly, Johnson & Johnson, Merck and Bristol Myers Squibb have also announced big investments this year to boost domestic production, as tariffs threaten to raise costs and President Donald Trump pushes to bring more manufacturing to America.  Gilead's five-story, 180,000-square-foot facility \"is part of our vision for delivering next generation therapies,\" said CEO Daniel O'Day.",
    "url": "https://ca.finance.yahoo.com/news/gilead-starts-building-manufacturing-hub-212418815.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "72573998-a483-30a8-87d2-d52fc3444711",
      "content": {
        "id": "72573998-a483-30a8-87d2-d52fc3444711",
        "contentType": "STORY",
        "title": "Gilead starts building manufacturing hub under $32 billion planned US investments",
        "description": "",
        "summary": "Major U.S. drugmakers such as Eli Lilly, Johnson & Johnson, Merck and Bristol Myers Squibb have also announced big investments this year to boost domestic production, as tariffs threaten to raise costs and President Donald Trump pushes to bring more manufacturing to America.  Gilead's five-story, 180,000-square-foot facility \"is part of our vision for delivering next generation therapies,\" said CEO Daniel O'Day.",
        "pubDate": "2025-09-03T21:24:18Z",
        "displayTime": "2025-09-03T21:24:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/7b708edc8a69377cd32bcbc19c86bc0a",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "FILE PHOTO: Gilead Sciences in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LGfccC7ipwFj421Bq18YCg--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/7b708edc8a69377cd32bcbc19c86bc0a.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Pts8DxLwussRKaULgX7eRQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/7b708edc8a69377cd32bcbc19c86bc0a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://ca.finance.yahoo.com/news/gilead-starts-building-manufacturing-hub-212418815.html",
          "site": "finance",
          "region": "CA",
          "lang": "en-CA"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-starts-building-manufacturing-hub-212418815.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-03T15:30:00+00:00",
    "headline": "Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy",
    "summary": "FOSTER CITY, Calif., September 03, 2025--Gilead Sciences (Nasdaq: GILD) today celebrates the groundbreaking of its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the company’s Foster City headquarters. This milestone marks continued momentum in Gilead’s multi-year strategy to drive growth and scientific leadership across virology, oncology, and inflammation, increasingly built on growing biologics capabilities. It is part of Gilead’s planned $32 bil",
    "url": "https://finance.yahoo.com/news/gilead-sciences-breaks-ground-manufacturing-153000652.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "e80294e7-d714-3e1d-bce8-5dc3e9b01656",
      "content": {
        "id": "e80294e7-d714-3e1d-bce8-5dc3e9b01656",
        "contentType": "STORY",
        "title": "Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy",
        "description": "",
        "summary": "FOSTER CITY, Calif., September 03, 2025--Gilead Sciences (Nasdaq: GILD) today celebrates the groundbreaking of its new Pharmaceutical Development and Manufacturing (PDM) Technical Development Center (NTDC) at the company’s Foster City headquarters. This milestone marks continued momentum in Gilead’s multi-year strategy to drive growth and scientific leadership across virology, oncology, and inflammation, increasingly built on growing biologics capabilities. It is part of Gilead’s planned $32 bil",
        "pubDate": "2025-09-03T15:30:00Z",
        "displayTime": "2025-09-03T15:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/bf4fc5e2b647e7fdf4fde12d6588434b",
          "originalWidth": 480,
          "originalHeight": 270,
          "caption": "Gilead Sciences breaks ground on new manufacturing and technical development site in Bay Area.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Cvfv7vNj.91nqm5NZDeuQQ--~B/aD0yNzA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bf4fc5e2b647e7fdf4fde12d6588434b.cf.webp",
              "width": 480,
              "height": 270,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KvKlXGLNu8NY59azYQ_oww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bf4fc5e2b647e7fdf4fde12d6588434b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-breaks-ground-manufacturing-153000652.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gilead-sciences-breaks-ground-manufacturing-153000652.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-03T04:36:52+00:00",
    "headline": "1 Healthcare Stock to Consider Right Now and 2 We Question",
    "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s return was flat while the S&P 500 climbed by 9.7%.",
    "url": "https://finance.yahoo.com/news/1-healthcare-stock-consider-now-043652946.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "fdbfe774-d48b-37ef-8155-979d7a28c0cf",
      "content": {
        "id": "fdbfe774-d48b-37ef-8155-979d7a28c0cf",
        "contentType": "STORY",
        "title": "1 Healthcare Stock to Consider Right Now and 2 We Question",
        "description": "",
        "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s return was flat while the S&P 500 climbed by 9.7%.",
        "pubDate": "2025-09-03T04:36:52Z",
        "displayTime": "2025-09-03T04:36:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/0c2e68ead77a9450e1fb435ed236802c",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "GILD Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7IhZSScYZ4CvnQJJpve_Dg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/0c2e68ead77a9450e1fb435ed236802c.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cv.0mSrHV7hG2Zeh2xc10A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/0c2e68ead77a9450e1fb435ed236802c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/1-healthcare-stock-consider-now-043652946.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/1-healthcare-stock-consider-now-043652946.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GILD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]